Biohaven Pharmaceutical Holding Stock Price on January 6, 2023

BHVN Stock  USD 54.69  2.33  4.09%   
If you're considering investing in Biohaven Stock, it is important to understand the factors that can impact its price. As of today, the current price of Biohaven Pharmaceutical stands at 54.69, as last reported on the 29th of March, with the highest price reaching 57.02 and the lowest price hitting 54.65 during the day. Biohaven Pharmaceutical appears to be very steady, given 3 months investment horizon. Biohaven Pharmaceutical secures Sharpe Ratio (or Efficiency) of 0.14, which signifies that the company had a 0.14% return per unit of risk over the last 3 months. By analyzing Biohaven Pharmaceutical's technical indicators, you can evaluate if the expected return of 0.5% is justified by implied risk. Please makes use of Biohaven Pharmaceutical's Downside Deviation of 2.77, risk adjusted performance of 0.0892, and Mean Deviation of 2.65 to double-check if our risk estimates are consistent with your expectations.
  
At this time, Biohaven Pharmaceutical's Total Stockholder Equity is very stable compared to the past year. As of the 29th of March 2024, Other Stockholder Equity is likely to grow to about 73.8 M, while Liabilities And Stockholders Equity is likely to drop about 347.2 M. . At this time, Biohaven Pharmaceutical's Price Book Value Ratio is very stable compared to the past year. As of the 29th of March 2024, Price Earnings To Growth Ratio is likely to grow to 0.14, while Price Earnings Ratio is likely to drop (7.84). Biohaven Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.1355

Best PortfolioBest Equity
Good Returns
Average Returns
Small ReturnsBHVN
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 3.71
  actual daily
32
68% of assets are more volatile

Expected Return

 0.5
  actual daily
9
91% of assets have higher returns

Risk-Adjusted Return

 0.14
  actual daily
10
90% of assets perform better
Based on monthly moving average Biohaven Pharmaceutical is performing at about 10% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Biohaven Pharmaceutical by adding it to a well-diversified portfolio.
Price Book
10.8799
Book Value
5.276
Enterprise Value
4.3 B
Enterprise Value Ebitda
(10.03)
Shares Float
65.9 M

Biohaven Pharmaceutical Valuation on January 6, 2023

It is possible to determine the worth of Biohaven Pharmaceutical on a given historical date. On January 6, 2023 Biohaven was worth 13.8 at the beginning of the trading date compared to the closed value of 14.43. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Biohaven Pharmaceutical stock. Still, in general, we apply an absolute valuation method to find Biohaven Pharmaceutical's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Biohaven Pharmaceutical where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Biohaven Pharmaceutical's related companies.
 Open High Low Close Volume
  14.34    14.65    13.59    13.78    714,267  
01/06/2023
  13.80    14.55    13.34    14.43    713,045  
  14.48    15.88    14.45    14.95    1,272,500  
Backtest Biohaven Pharmaceutical  |  Biohaven Pharmaceutical History  |  Biohaven Pharmaceutical Valuation   PreviousNext  
Open Value
13.8
14.43
Closing Value
24.92
Upside

Biohaven Pharmaceutical Trading Date Momentum on January 6, 2023

On January 09 2023 Biohaven Pharmaceutical Holding was traded for  14.95  at the closing time. The top price for the day was 15.88  and the lowest listed price was  14.45 . The trading volume for the day was 1.3 M. The trading history from January 9, 2023 was a factor to the next trading day price boost. The overall trading delta against the next closing price was 3.60% . The overall trading delta against the current closing price is 29.38% .

Biohaven Pharmaceutical Fundamentals Correlations and Trends

By evaluating Biohaven Pharmaceutical's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Biohaven Pharmaceutical's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Biohaven financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Biohaven Pharmaceutical Stock history

Biohaven Pharmaceutical investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Biohaven is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Biohaven Pharmaceutical will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Biohaven Pharmaceutical stock prices may prove useful in developing a viable investing in Biohaven Pharmaceutical
Last ReportedProjected for 2024
Common Stock Shares Outstanding71.2 M51.9 M
Net Loss-513.3 M-538.9 M

Biohaven Pharmaceutical Quarterly Net Working Capital

387.02 Million

Biohaven Pharmaceutical Stock Technical Analysis

Biohaven Pharmaceutical technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Biohaven Pharmaceutical technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Biohaven Pharmaceutical trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Biohaven Pharmaceutical Period Price Range

Low
January 6, 2023
0.63  4.57%
High

 13.80 

     

 14.43 

Biohaven Pharmaceutical March 29, 2024 Market Strength

Market strength indicators help investors to evaluate how Biohaven Pharmaceutical stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Biohaven Pharmaceutical shares will generate the highest return on investment. By undertsting and applying Biohaven Pharmaceutical stock market strength indicators, traders can identify Biohaven Pharmaceutical Holding entry and exit signals to maximize returns

Biohaven Pharmaceutical Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Biohaven Pharmaceutical's price direction in advance. Along with the technical and fundamental analysis of Biohaven Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Biohaven to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
When determining whether Biohaven Pharmaceutical offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Biohaven Pharmaceutical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biohaven Pharmaceutical Holding Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biohaven Pharmaceutical Holding Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biohaven Pharmaceutical Holding. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real.
You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.

Complementary Tools for Biohaven Stock analysis

When running Biohaven Pharmaceutical's price analysis, check to measure Biohaven Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biohaven Pharmaceutical is operating at the current time. Most of Biohaven Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Biohaven Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biohaven Pharmaceutical's price. Additionally, you may evaluate how the addition of Biohaven Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Equity Valuation
Check real value of public entities based on technical and fundamental data
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Is Biohaven Pharmaceutical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biohaven Pharmaceutical. If investors know Biohaven will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biohaven Pharmaceutical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(5.73)
Return On Assets
(0.46)
Return On Equity
(0.84)
The market value of Biohaven Pharmaceutical is measured differently than its book value, which is the value of Biohaven that is recorded on the company's balance sheet. Investors also form their own opinion of Biohaven Pharmaceutical's value that differs from its market value or its book value, called intrinsic value, which is Biohaven Pharmaceutical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biohaven Pharmaceutical's market value can be influenced by many factors that don't directly affect Biohaven Pharmaceutical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biohaven Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biohaven Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biohaven Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.